Kakamega County, Kenya, USA, 09/26/2022 / SubmitMyPR /
Immunify.Lifea transformative blockchain-based healthcare ecosystem, in partnership with Masinde Muliro University of Science and Technology (MMUST) – the leading science, technology and innovation university in Kenya – has completed the groundwork for a large-scale HIV/AIDS treatment outcomes study that is now officially launched. As part of the study, Immunify.Life’s data collection and processing platform will be used to empower patients, communities and entire countries by using token rewards that demonstrate adherence to medical regimens in HIV/AIDS patients with previously expired therapy can improve.
The HIV/AIDS Treatment Outcomes Study is an elegant application of Immunify.Life technology and the results of the study will inform future HIV treatment strategy in Kenya
According to health department coordinators in Kakamega County, there were more than 1,000 patients with high viral loads in July, which could indicate treatment failure. This means that this study is not only necessary, but also timely. Kenya has one of the world’s largest populations of people living with HIV/AIDS and approximately 30% are not receiving treatment. In addition, 42% of all new HIV infections in Kenya are adolescents and young adults.
Guy Newing, CEO of Immunify.Life commented on the study, saying: “The technology we use at Immunify.Life is designed to address the challenges of HIV and AIDS, tuberculosis and immunization programs. Blockchain technology is the game-changing new frontier technology that will revolutionize healthcare in Africa.”
dr Charles Mutai, Professor at the Faculty of Medicine at MMUST, said: “Our Vice-Chancellor is keen to strengthen research capacities and has advocated the establishment of research teams to draft proposals in different areas. This project will therefore receive the necessary administrative support. We anticipate that this project can be used to touch lives…
